Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ageless vs Enhance MD

Ageless
Graded #24

Lower grade

vs+2
Enhance MD
Graded #14

Higher grade

The verdict

Enhance MD takes it — 85/100 to 83/100, but only just.

Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side. Ageless is close behind and may still be the better fit — see the factor split below.

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never changes the WeighScore.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAgeless +8
90
82
Dose & formulationAgeless +8
90
82
Clinical oversightEnhance MD +8
80
88
Labs & monitoringEnhance MD +12
78
90
FulfillmentEven
84
84
Contract termsEnhance MD +2
82
84
Ageless · left barEnhance MD · right bar

The numbers

MetricAgelessEnhance MD
WeighScore83/10085/100
GradeBB
Scorecard rank#24#14
Semaglutide$119/mo$212/mo
Tirzepatide$169/mo$280/mo
CoverageVaries by stateNot publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Ageless

Graded #24 · B

Strengths

  • Unusually broad compounded menu — GLP-1, NAD+, sermorelin, TRT, LDN and more, in both injectable and oral formats
  • Low headline GLP-1 pricing — semaglutide $119/mo, tirzepatide $169/mo — no insurance, with Klarna/Affirm financing
  • Fully online: licensed-clinician review and discreet delivery, with upfront compounded/not-FDA disclosures
  • Oral routes available (drops and troches), not injection-only

Where it loses points

  • Everything is compounded and not FDA-approved — not equivalent to brand Wegovy/Ozempic/Zepbound
  • Oral GLP-1 drops and troches lack robust absorption/efficacy evidence versus injectables
  • No published state-availability list and no named legal entity or medical group
  • Thin public track record, and advertised prices are floors set after clinical review
Enhance MD

Graded #14 · B

Strengths

  • Transparent tiered pricing across sema, tirz, microdose, and combo
  • Dose-flat — the price does not step up as you titrate
  • Six-month lab testing plus provider-led care
  • NAD+ longevity adjacency available

Where it loses points

  • Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
  • No oral or sublingual route
  • States served are not published
  • Higher entry price than the cheapest compounded programs

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 34 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard